Groundbreaking trial targets aging at cellular level

Name: Groundbreaking trial targets aging at cellular level
Uploaded: 2026-06-15T23:04:57Z
Duration: 1 min 7 s
Description: Bret Baier introduces a clinical trial aimed at reversing vision loss by reprogramming cells to act younger. Alexandra Hoff reports on Life Biosciences' ER 100 gene therapy, which 'cleans up' DNA instructions. Co-founder Dr. David Sinclair expresses optimism about the study's potential to ameliorate human disease, hinting at broader anti-aging applications.

Special Report With Bret Baier · FNC · Aired Jun 15 · 1m 7s

Watch Now

Already a subscriber?

Bret Baier introduces a clinical trial aimed at reversing vision loss by reprogramming cells to act younger. Alexandra Hoff reports on Life Biosciences' ER 100 gene therapy, which 'cleans up' DNA instructions. Co-founder Dr. David Sinclair expresses optimism about the study's potential to ameliorate human disease, hinting at broader anti-aging applications.